Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Making NICE nicer

This article was originally published in The Gray Sheet

Executive Summary

UK's National Institute of Clinical Excellence should consider directing the National Health Service to evaluate medical device "effectiveness versus efficacy" in cases where randomized controlled trial data are absent, according to the Association of British Health-Care Industries. "Adherence to the hierarchy of evidence necessarily biases the work of NICE against non-pharmaceutical products," ABHI asserts, noting that device makers are "unlikely to have such large-scale studies," relying instead on "naturalistic study designs such as registries." In January testimony responding to the House of Commons Health Committee's inquiry of NICE, the device trade group urged a more transparent topic selection process and warned of technologies becoming "sidelined" if they are not chosen for NICE appraisal...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT016091

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel